SUPER-REFRACTORY STATUS EPILEPTICUS

Clinical trials for SUPER-REFRACTORY STATUS EPILEPTICUS explained in plain language.

Never miss a new study

Get alerted when new SUPER-REFRACTORY STATUS EPILEPTICUS trials appear

Sign up with your email to follow new studies for SUPER-REFRACTORY STATUS EPILEPTICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 2

Experimental drug offers hope for patients with unstoppable seizures

Disease control NO_LONGER_AVAILABLE

This study provided expanded access to an experimental drug called SAGE-547 for patients with super-refractory status epilepticus—a severe, life-threatening condition where seizures continue despite multiple standard treatments. The trial aimed to evaluate whether a continuous in…

Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS

Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

SUPER-REFRACTORY STATUS EPILEPTICUS

Get alerted when new SUPER-REFRACTORY STATUS EPILEPTICUS trials appear

Experimental drug offers hope for patients with unstoppable seizures